Malignant neoplasm of the oral cavity and oropharynx and hypopharynx - Smoking tobacco products - material contribution Factor
Last reviewed for CCPS 05 October 2005.
Investigative Documents
Claimant Report - Smoking [CRD905]
Claimant Report - Smoking [CRV905]
Preliminary questions [34928]
the veteran has smoked cigarettes, cigars or pipe tobacco at some time.34929 — the veteran has established the causal connection between smoking tobacco products and VEA service for the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx.
34930 — the veteran has established the causal connection between smoking tobacco products and operational service for the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx.
or
34931 — the veteran has established the causal connection between smoking tobacco products and eligible service for the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx.
Clinical onset and operational service [34930]
the veteran smoked at least 2.5 pack years of cigarettes or the equivalent thereof in other tobacco products before the clinical onset of the condition under consideration and, where smoking had ceased, at least some smoking was maintained in the 15 years before the clinical onset of the condition under consideration. smoking as a causal result of operational service made a material contribution to the SOP requirements for malignant neoplasm of the oral cavity, oropharynx and hypopharynx and smoking tobacco products.Clinical onset and eligible service [34931]
the veteran smoked at least five pack years of cigarettes or the equivalent thereof in other tobacco products before the clinical onset of the condition under consideration and, where smoking had ceased, at least some smoking was maintained in the 10 years before the clinical onset of the condition under consideration. smoking as a causal result of eligible service made a material contribution to the SOP requirements for malignant neoplasm of the oral cavity, oropharynx and hypopharynx and smoking tobacco products.